臨床試験イメージングの世界市場予測2021:CT、MRI、PET、超音波、心エコー検査、X線検査

◆英語タイトル:Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021
◆商品コード:MAM-MD-4818
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2016年12月13日
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、臨床試験イメージングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス別分析、種類別分析、需要先別分析、地域別分析、臨床試験イメージングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・臨床試験イメージングの世界市場:市場インサイト
・臨床試験イメージングの世界市場:市場概観/市場動向
・臨床試験イメージングの世界市場:製品・サービス別分析/市場規模
・臨床試験イメージングの世界市場:種類別分析/市場規模
・臨床試験イメージングの世界市場:需要先別分析/市場規模
・臨床試験イメージングの世界市場:地域別分析/市場規模
・臨床試験イメージングのアジア市場規模予測
・臨床試験イメージングのヨーロッパ市場規模予測
・臨床試験イメージングのアメリカ市場規模予測
・臨床試験イメージングの世界市場動向
・臨床試験イメージングの世界市場:競争状況
・臨床試験イメージングの世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

The global clinical trial imaging market is projected to reach USD 1069.7 Million by 2021 from USD 773.4 Million in 2016, at a CAGR of 6.7% from 2016 to 2021.In this report, the global market is broadly segmented by product and service, modality, end user, and region.
Major factors fueling market growth are the increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the market. On the other hand, the high implementation cost of imaging systems is restraining the growth of this market.

On the basis of product and service, the market is segmented into service and software. The service segment is expected to account for the largest share of the market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers.

Furthermore, On the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities (such as magnetic resonance elastography (MRE) and dual-energy X-ray absorptiometry (DXA)). In 2016, the CT segment is expected to account for the largest share of the global market. The large share of this segment is attributed to the high advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body.

On the basis of end user, the market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users (cosmetics and skin care companies). Pharmaceutical companies are expected to account for the largest share of the global market in 2016. Increased R&D budgets of pharmaceutical companies is the primary growth driver for this end-user segment.

Geographically, the clinical trial imaging market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to command the largest share of the global market in 2016. This market is primarily driven by large R&D spending, growing number of pharmaceutical & biotechnology companies, and increasing number of CROs. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region.

The key players in the global clinical trial imaging market are BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), BioTelemetric, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in The Study
1.4 Currency
1.5 Limitation
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Rank Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.3.4 Assumptions for The Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 27)
4.1 Clinical Trial Imaging: Market Overview
4.2 Clinical Trial Imaging Market, By Product & Service, 2016
4.3 Clinical Trial Imaging Market Size, By Modality, 2016 vs 2021
4.4 Clinical Trial Imaging Market Size, By End User, 2016 vs 2021
4.5 Geographic Snapshot of The Clinical Trial Imaging Market
4.6 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in R&D Spending
5.2.1.2 Growth in The Pharmaceutical and Biotechnology Industries
5.2.1.3 Increasing Number of Cros
5.2.2 Restraints
5.2.2.1 High Implementation Cost of Imaging Systems
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, and Radiopharmaceuticals
5.2.4 Challenges
5.2.4.1 High Cost of Clinical Trials
5.2.4.2 High Cost of Pet
5.3 Recent Market Trends
5.3.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials
5.4 Regulatory Scenario
5.5 Clinical Trials: Global Scenario

6 Clinical Trial Imaging Market, By Product and Service (Page No. – 39)
6.1 Introduction
6.2 Services
6.2.1 Operational Imaging Services
6.2.2 Read Analysis Services
6.2.3 System and Technical Support Services
6.2.4 Trial Design Consulting Services
6.3 Software

7 Clinical Trial Imaging Market, By Modality (Page No. – 48)
7.1 Introduction
7.2 Computed Tomography
7.3 Magnetic Resonance Imaging
7.4 Ultrasound
7.5 Positron Emission Tomography
7.6 X-Ray
7.7 Echocardiography
7.8 Other Modalities

8 Clinical Trial Imaging Market, By End User (Page No. – 57)
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Biotechnology Companies
8.4 Medical Device Manufacturers
8.5 Contract Research Organizations
8.6 Academic and Government Research Institutes
8.7 Other End Users

9 Clinical Trial Imaging Market, By Region (Page No. – 68)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of The World (RoW)

10 Competitive Landscape (Page No. – 89)
10.1 Introduction
10.2 Strategic Overview
10.3 Competitive Situation and Trends
10.4 Leading Players in The Clinical Trial Imaging Market
10.4.1 Agreements, Collaborations, and Partnerships
10.4.2 Expansion
10.4.3 Acquisition
10.4.4 Product and Service Launches & Product Upgrades

11 Company Profiles (Page No. – 95)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Bioclinica, Inc.
11.3 Parexel International Corporation
11.4 Icon PLC
11.5 Biomedical Systems Corporation
11.6 Biotelemetry, Inc.
11.7 Cardiovascular Imaging Technologies, LLC
11.8 Intrinsic Imaging LLC
11.9 Ixico PLC
11.10 Radiant Sage LLC
11.11 Worldcare Clinical, LLC
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 112)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports
12.8 Author Details

List of Tables (77 Tables)

Table 1 Phases of Clinical Trials
Table 2 Global Scenario of Clinical Trials Till 2015
Table 3 Clinical Trial Imaging Market Size, By Product and Service, 2014–2021 (USD Million)
Table 4 Clinical Trial Imaging Services Market Size, By Type, 2014–2021 (USD Million)
Table 5 Clinical Trial Imaging Services Market Size, By Region, 2014–2021 (USD Million)
Table 6 North America: Clinical Trial Imaging Services Market Size, By Country, 2014–2021 (USD Million)
Table 7 Operational Imaging Services Market Size, By Region, 2014–2021 (USD Million)
Table 8 North America: Operational Imaging Services Market Size, By Country, 2014–2021 (USD Million)
Table 9 Read Analysis Services Market Size, By Region, 2014–2021 (USD Million)
Table 10 North America: Read Analysis Services Market Size, By Country, 2014–2021 (USD Million)
Table 11 System and Technical Support Services Market Size, By Region, 2014–2021 (USD Million)
Table 12 North America: System and Technical Support Services Market Size, By Country, 2014–2021 (USD Million)
Table 13 Trial Design Consulting Services Market Size, By Region, 2014–2021 (USD Million)
Table 14 North America: Trial Design Consulting Services Market Size, By Country, 2014–2021 (USD Million)
Table 15 Clinical Trial Imaging Software Market Size, By Region, 2014–2021 (USD Million)
Table 16 North America: Clinical Trial Imaging Software Market Size, By Country, 2014–2021 (USD Million)
Table 17 Market Size, By Modality, 2014–2021 (USD Million)
Table 18 Market Size for CT, By Region, 2014–2021 (USD Million)
Table 19 North America: Market Size for CT, By Country, 2014–2021 (USD Million)
Table 20 Market Size for Mri, By Region, 2014–2021 (USD Million)
Table 21 North America: Market Size for Mri, By Country, 2014–2021 (USD Million)
Table 22 Market Size for Ultrasound, By Region, 2014–2021 (USD Million)
Table 23 North America: Market Size for Ultrasound, By Country, 2014–2021 (USD Million)
Table 24 Market Size for Pet, By Region, 2014–2021 (USD Million)
Table 25 North America: Market Size for Pet, By Country, 2014–2021 (USD Million)
Table 26 Market Size for X-Ray, By Region, 2014–2021 (USD Million)
Table 27 North America: Market Size for X-Ray, By Country, 2014–2021 (USD Million)
Table 28 Market Size for Echocardiography, By Region, 2014–2021 (USD Million)
Table 29 North America: Market Size for Echocardiography, By Country, 2014–2021 (USD Million)
Table 30 Market Size for Other Modalities, By Region, 2014–2021 (USD Million)
Table 31 North America: Market Size for Other Modalities, By Country, 2014–2021 (USD Million)
Table 32Market Size, By End User, 2014–2021 (USD Million)
Table 33 Market Size, By Region, 2014–2021 (USD Million)
Table 34 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 35 Market Size for Pharmaceutical Companies, By Region, 2014–2021 (USD Million)
Table 36 North America: Market Size for Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 37 Market Size for Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 38 North America: Market Size for Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 39 Market Size for Medical Device Manufacturers, By Region, 2014–2021 (USD Million)
Table 40 North America: Market Size for Medical Device Manufacturers, By Country, 2014–2021 (USD Million)
Table 41 Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 42 North America: Market Size for Contract Research Organizations , By Country, 2014–2021 (USD Million)
Table 43 Market Size for Academic and Government Research Institutes, By Region, 2014–2021 (USD Million)
Table 44 North America: Market Size for Academic and Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 45 Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 46 North America: Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 47 Market Size, By Region, 2014–2021 (USD Million)
Table 48 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 49 North America: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 50 North America: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 51 North America: Market Size, By Modality, 2014–2021 (USD Million)
Table 52 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 53 U.S.: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 54 U.S.: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 55 U.S.: Market Size, By Modality, 2014–2021 (USD Million)
Table 56 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 57 Canada: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 58 Canada: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 59 Canada: Market Size, By Modality, 2014–2021 (USD Million)
Table 60 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 61 Europe: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 62 Europe: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 63 Europe: Market Size, By Modality, 2014–2021 (USD Million)
Table 64 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 65 Asia: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 66 Asia: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 67 Asia: Market Size, By Modality, 2014–2021 (USD Million)
Table 68 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 69 RoW: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 70 RoW: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 71 RoW: Market Size, By Modality, 2014–2021 (USD Million)
Table 72 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 73 Rank of Companies in The Global Clinical Trial Imaging Market, 2015
Table 74 Agreements, Collaborations, and Partnerships, 2013–2016
Table 75 Expansions, 2013–2016
Table 76 Acquisitions, 2013–2016
Table 77 Product and Service Launches & Product Upgrades, 2013–2016

List of Figures (32 Figures)

Figure 1 Clinical Trial Imaging Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product & Service, 2016 vs 2021 (USD Million)
Figure 8 Market Size, By Modality, 2016 vs 2021 (USD Million)
Figure 9 Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographic Snapshot of The Market
Figure 11 Emerging Economies Offer Significant Growth Opportunities for Players in The Market
Figure 12 Services Segment to Account for The Largest Share of The Market in 2016
Figure 13 Pet Modality Segment to Register The Highest CAGR During The Forecast Period
Figure 14 Pharmaceutical Companies to Account for The Largest Market Share in 2016
Figure 15 Asia to Register The Highest Growth Rate From 2016 to 2021
Figure 16 Asia Offers Significant Growth Opportunities in The Forecast Period
Figure 17 Increase in R&D Spending Will Drive The Growth of The Clinical Trial Imaging Market
Figure 18 Clinical Trial Imaging Services to Form The Largest Segment in 2016
Figure 19 CT Segment to Dominate The Clinical Trial Imaging Market in 2016
Figure 20 Pharmaceutical Companies to Account for The Largest Share of The Clinical Trial Imaging Market in 2016
Figure 21 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region
Figure 22 North America to Dominate The Clinical Trial Imaging Market During The Forecast Period
Figure 23 Clinical Trial Imaging Market in Asia Expected to Grow at The Highest Rate During The Forecast Period
Figure 24 North America: Clinical Trial Imaging Market Snapshot
Figure 25 Asia: Clinical Trial Imaging Market Snapshot
Figure 26 Agreements, Partnerships, and Collaborations is The Key Growth Strategy Adopted By Players in The Clinical Trials Imaging Market
Figure 27 Battle for Market Share: Agreements, Collaborations, and Partnerships: The Key Strategies Adopted By Players Between January 2013 and October 2016
Figure 28 Geographic Revenue Mix of The Top Three Market Players
Figure 29 Company Snapshot: Parexel International Corporation
Figure 30 Company Snapshot: Icon PLC
Figure 31 Company Snapshot: Biotelemetry, Inc.
Figure 32 Company Snapshot: Ixico PLC

【レポートのキーワード】

臨床試験イメージング、CT検査、MRI検査、PET検査、超音波、心エコー検査、X線検査、画像診断、治験画像検査、医療機器、ソフトウェア、サービス

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 臨床試験イメージングの世界市場予測2021:CT、MRI、PET、超音波、心エコー検査、X線検査(Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆